SCHEMBL4777321

SCHEMBL4777321

CS(=O)(=O)N(Cc1cccc(Cl)c1Cl)c1ccc(C(=O)NCCN2CCOCC2)cc1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
CD274 Q9NZQ7 3/20 0.54
HTR1A P08908 1/20 0.54
MAOA P21397 1/20 0.54
MAOB P27338 1/20 0.54
KCNH2 Q12809 1/20 0.54
HPGD P15428 1/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA9 Q16790 1/20 0.50
KMT2A Q03164 1/20 0.49
EPHX2 P34913 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 1/20 0.48
LMNA P02545 1/20 0.48
HTT P42858 1/20 0.48
POLB P06746 1/20 0.47
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4777569 0.95 CA12 (0.51) ALDH1A1CD274HTR1AMAOAMAOB
SCHEMBL5571358 0.92 ALDH1A1 (0.54) ALDH1A1CA12CA9KMT2AGAA
SCHEMBL4777371 0.91 ALDH1A1 (0.57) ALDH1A1HTR1AKMT2AGAA
SCHEMBL5571747 0.89 ALDH1A1 (0.51) ALDH1A1KMT2ASMN1; SMN2GAA
SCHEMBL5571881 0.89 ALDH1A1 (0.51) ALDH1A1HTR1AKMT2AGAALMNA
SCHEMBL5572343 0.87 ALDH1A1 (0.49) ALDH1A1HTR1AKMT2AGAA
SCHEMBL4777469 0.87 ALDH1A1 (0.49) ALDH1A1HTR1AKMT2AGAA
SCHEMBL5572112 0.86 ALDH1A1 (0.52) ALDH1A1HTR1AKMT2ASMN1; SMN2GAA
SCHEMBL4795230 0.86 ALDH1A1 (0.56) ALDH1A1HTR1AKMT2AGAALMNA
SCHEMBL4770929 0.86 ALDH1A1 (0.51) ALDH1A1HTR1AKMT2ASMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP claimed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US claimed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO claimed
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP disclosed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US disclosed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135435-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 ALDH1A1 2159/4885CD274 4134/4885HTR1A 4361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.